+86-28-82633987
Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃
63.6000
3.1531
3.0165
.0136
6.3833
20.2730
High
91.5709
2.0981
Yes
No
No
No
Yes
Yes
1.2
Yes
No
Yes
No
8-Methyl Chrysophanol (CAS No.: 3300-25-2) is a typical anthraquinone natural product, first isolated from the bark of Senna macranth. As an important member of anthraquinone compounds, 8-methylemosulfol has attracted significant attention in natural medicine research in recent years due to its unique chemical structure and diverse biological activities. Especially in terms of laxative effects, it regulates intestinal ion channels and transporters, affecting water-salt balance and demonstrating significant pharmacological effects. This paper will systematically review the chemical structure and physicochemical properties of 8-methylefainol, plant origin and extraction methods, pharmacological activity and mechanism of action, druggability evaluation and pharmacokinetic characteristics, and explore its clinical application prospects and development directions.
8-Methylehunophenol belongs to the anthraquinone class of compounds, with the chemical formula C16H12O4 and a molecular weight of 268.2680. Its structural core is an anthraquinone framework, with methyl substituents introduced at position 8, giving it unique chemical properties and biological activity. The molecular structure contains two hydroxyl groups and two ketone groups, forming a stable conjugated system with a strong electron cloud density distribution, which facilitates interaction with biological macromolecules.
In terms of physicochemical properties, the LogP value of 8-methylemosulfin is 3.1531, indicating moderate lipid solubility that facilitates cell membrane penetration. The polarized surface area (TPSA) was 63.6 Ų, indicating a balance between molecular polarity and hydrophilicity, which is beneficial for improving bioavailability. Low water solubility (0.0136 mg/mL), which poses certain challenges for formulation development. The blood-brain barrier has a relatively high penetration ability, suggesting it may have some impact on the central nervous system. The hERG channel inhibition test was negative, indicating a low risk of cardiotoxicity. The Ames test result was 1.2, indicating low genotoxicity risk and good safety.
8-Methylehunophenol is mainly found in the bark of Senna macranth (Senna senna tree). Senna macranth, as a traditional Chinese medicinal herb, is widely distributed in tropical and subtropical regions and has long been used to treat constipation and related intestinal diseases. The bark of this plant is rich in anthraquinone components, with 8-methylecryptol being one of the important active components.
The extraction process typically combines organic solvent extraction with column chromatography separation. Common extraction solvents include ethanol, methanol, and ethyl acetate, which can effectively dissolve anthraquinone compounds. The typical extraction process includes: crushing plant material→ extraction → concentration→ solvent extraction→ silica gel column chromatography→ and high-performance liquid chromatography (HPLC) purification. In recent years, ultrasound-assisted extraction and microwave-assisted extraction technologies have also been applied to improve extraction efficiency and purity. During extraction and purification, care must be taken to avoid high temperatures and strong acidic or alkaline conditions to prevent degradation of the anthraquinone skeleton.
Pharmacological activity studies of 8-methylemodol mainly focus on its laxative effect and related intestinal regulatory functions. Multiple in vivo and in vitro experiments have shown that this compound can significantly promote intestinal peristalsis, increase the water content in intestinal contents, and thus exert a laxative effect.
In animal models, 8-methylemodolol regulates intestinal ion channels and aquaporins, promotes the secretion of sodium and chloride ions, enhances osmotic pressure in the intestinal lumen and passively enters the intestinal lumen, softens stool, and shortens bowel movement time. Additionally, this compound exhibits anti-inflammatory and antioxidant activities, which may help relieve intestinal inflammation and improve intestinal dysfunction.
In addition to laxative effects, preliminary studies have also found that 8-methylrhein has the potential to inhibit proliferation in certain tumor cells, but the related mechanisms require further elucidation.
The laxative effect of 8-methylefanophenol is mainly achieved by regulating various intestinal ion channels and transport proteins, with key targets including:
By regulating these targets, 8-methylehunophenol can coordinate the transport of ions and water in the intestines, promote intestinal peristalsis and secretion, and achieve a laxative effect. Additionally, its inhibitory effect on intestinal inflammatory factors may indirectly improve intestinal barrier function and enhance drug efficacy.
In terms of druggability, 8-methyl efafenol exhibits relatively ideal drug properties. Its molecular weight is moderate, and the LogP value shows good lipid solubility, which is beneficial for oral absorption and cell membrane penetration. TPSA is moderate, supporting good bioavailability. Water solubility is relatively low, suggesting that formulation optimization should be used to improve dissolution and bioavailability.
The blood-brain barrier has a relatively high penetration ability, suggesting it may have some impact on the central nervous system, so attention should be paid to potential central nervous system side effects. hERG channel inhibition negative, reducing the risk of cardiotoxicity. Ames test results showed low genotoxicity risk and good safety.
Pharmacokinetic research is still in its early stages. Metabolism in the body may mainly occur through the hepatic enzyme system, involving corresponding oxidation and reduction reactions. Excretion routes may mainly be bile and urine. In the future, systematic absorption, distribution, metabolism, excretion (ADME) and toxicological assessments are needed to provide a basis for clinical development.
As a natural anthraquinone laxative, 8-methylemosulfol has a clear pharmacological basis and good safety, showing potential for development as a new laxative. It regulates intestinal ion and water channels through multiple targets, with a clear mechanism and significant effects, offering new treatment options for chronic constipation, intestinal dysfunction, and other diseases.
Moreover, its anti-inflammatory and antioxidant activities offer possibilities for comprehensive treatment of intestinal diseases, and future applications in fields such as inflammatory bowel disease and irritable bowel syndrome can be explored. Given its ability to penetrate the blood-brain barrier, its potential role in central nervous system-related diseases may also be considered.
However, current research still has shortcomings, such as incomplete pharmacokinetic characteristics, lack of long-term safety evaluation, and insufficient clinical trial data. In the future, research on in vivo and in vitro mechanisms should be strengthened, formulation technology optimized, systematic toxicology and clinical evaluations carried out, and clinical translation to promote clinical application.
8-Methylefainol, a natural anthraquinone compound derived from the bark of Senna macranth, demonstrates broad research and application prospects in the field of natural product pharmacology due to its unique chemical structure and multi-target laxative mechanism. Its excellent druggability parameters and safety laid the foundation for the development of new laxatives. In the future, by integrating modern drug development technologies and deeply exploring its pharmacological mechanisms and clinical applications, it is expected that 8-methylemosulfinol will become an important drug for treating intestinal diseases and provide a model for the development of natural product drugs.
Shenshuai
Wenjing
Hedandan
